维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Kupsch P"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Results of a phase Ⅰ trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer显示文摘	Richly H Kupsch P Passage K	2004	Int J Clin Pharmacol Ther2004，42，11：	1
2	Results of a phase I trial of sorafenib (BAY 43 9006) in combination with doxorubi cin in patients with refractory solid tumors显示文摘	Richly H Henning B F Kupsch P	2006	Ann Oncol2006，17，5：	1
3	Results of a phase I trial of sorafenib (BAY 43-9006) in combination with doxo-rubicin in patients with refractory solid tumors显示文摘	Richly H Henning BF Kupsch P	2006	Ann Oncol2006，17，：	1
4	Results of a phase Ⅰ trial of BAY 43 - 9006 in combination with doxorubicin in patients with primary hepatic cancer显示文摘	Richly H Kupsch P Passage K	2004	Int J Clin Pharmacol Ther2004，42，11：	1
5	Mutations in the connexin 26/GJB2 gene are the most common event in nonsyndromic hearing loss among the German population显示文摘	Gabriel H Kupsch P Sudendey J		0，，：	1
6	Results of a phase Ⅰ trial of sorafenib ( BAY 43-9006 ) in combination with doxorubicin in patients with refractory solid tumors 显示文摘	RICHLY H KUPSCH P PASSAGE K	2006	Anna Onco2006，17，5：	1
7	Mutations in the connexin26/GJB2 gene are the most commen event in non - sydromic hearing loss among the German population 显示文摘	Gabriel H Kupsch P Sudendey J	2001	Hum Mutat2001，17，：	1
8	Results of a PhaseⅠtrial of sorafenib (BAY 4329006) in combination with doxorubicin in patients with refractory solid tumors显示文摘	Richly H Henning BF Kupsch P	2006	Ann Oncol2006，17，5：	1
9	Evidence of phase transition in decagonal Al-Co-Ni at low temperatures显示文摘	KUPSCH A MEYER D C GILLE P	2002	J Alloys Comp2002，336，：	1
10	Results of a phase Ⅰ trial of Sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors,including colorectal cancer显示文摘	KUPSCH P HENNING BF PASSARGE K	2005	Clin Colorectal Cancer2005，5，3：	1
11	Results of a Phase Ⅰ trial of Sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors显示文摘	RICHLY H HENNING BF KUPSCH P	2006	Ann Oncol2006，17，5：	1
12	Results of a Phase I trial of sorafenib (BAY 43-9006 ) in combination with doxorubicin in patients with refractory solid tumors显示文摘	Richly H Henning BF Kupsch P	2006	Ann On- col2006，17，5：	1
13	Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer显示文摘	Richly H Kupsch P Passage K	2004	Int J Clin Pharmacol Ther2004，42，11：	1
14	Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors,including colorectal cancer显示文摘	Kupsch P Henning BF Passarge K	2005	Clin Colorectal Cancer2005，5，3：	1
15	Results of a phase cntrial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors显示文摘	Richly H Henning BF Kupsch P	2006	Ann Oncol2006，17，5：	1
16	Results of a phase I trial of sorafenib ( BAY 43-9006) in combination with ox- aliplatin in patients with refractory solid tumors, including color- ectal cancer显示文摘	KUPSCH P HENNING BF PASSARGE K	2005	Clin Colorectal Cancer2005，5，3：	1
17	Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with re fractory solid tumors, including colorectal cancer 显示文摘	Kupsch P Henning B F Passarge K	2005	Clin Colorectal Cancer2005，5，3：	1
18	Results of a Phase Ⅰ trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors 显示文摘	Richly H Henning BF Kupsch P	2006	Ann Oncol2006，17，5：	1
19	Results ot a phase I trial of sorafenib (BAY 43 - 9006) in combination with doxorubicin in patients with refractory solid tumors 显示文摘	Richly H Henning BF Kupsch P	2006	Ann Oncol2006，17，5：	1
20	Results of a Phase Ⅰ trial of sorafenib ( BAY 43-9006 ) in combination with doxorubicin in patients with refractory solid tumors 显示文摘	RICHLY H HENNING B F KUPSCH P	2006	Ann Oncol2006，17，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示